Novel use of 177Lu-DOTA-RGD2 in treatment of 68Ga-DOTA-RGD2-avid lesions in papillary thyroid cancer with TENIS

@article{Parihar2018NovelUO,
  title={Novel use of 177Lu-DOTA-RGD2 in treatment of 68Ga-DOTA-RGD2-avid lesions in papillary thyroid cancer with TENIS},
  author={Ashwin Singh Parihar and Ashwani Sood and Rajender Kumar and Priya Bhusari and Jaya Shukla and Bhagwant Rai Mittal},
  journal={European Journal of Nuclear Medicine and Molecular Imaging},
  year={2018},
  pages={1-2}
}
Thyroglobulin elevation with negative I scintigraphy (TENIS) in patients with differentiated thyroid carcinoma (DTC) poses a unique management challenge to the physician due to limited treatment modalities. Treatment with chemo-radiation, redifferentiation therapy, tyrosine kinase inhibitors and peptide receptor radionuclide therapy (PRRT) using… CONTINUE READING